P. Maddison

发表

Clinical validation of an autoantibody test for lung cancer

P. Boyle, J. Robertson, W. Wood, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Human hippocampal CA3 damage disrupts both recent and remote episodic memories

Clive R. Rosenthal, C. Kennard, M. Husain, 2020, eLife.

Focal CA3 hippocampal subfield atrophy following LGI1 VGKC-complex antibody limbic encephalitis

Michael R. Johnson, Clive R. Rosenthal, C. Kennard, 2017, Brain : a journal of neurology.

Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis

A. Monaco, M. Brin, J. Volkmann, 2002, European Journal of Human Genetics.

Phenotypic variants of autoimmune peripheral nerve hyperexcitability.

K. Mills, A. Vincent, J. Newsom-Davis, 2002, Brain : a journal of neurology.

Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes

A. Vincent, U. Sheerin, H. Meinck, 2014, Brain : a journal of neurology.

Myasthenia gravis: Association of British Neurologists’ management guidelines

M. Farrugia, M. Leite, D. Hilton‐Jones, 2015, Practical Neurology.

Treatment in Lambert–Eaton myasthenic syndrome

P. Maddison, 2012, Annals of the New York Academy of Sciences.

Long term outcome in Lambert-Eaton myasthenic syndrome without lung cancer

K. Mills, K. Mills, J. Newsom-Davis, 2001, Journal of neurology, neurosurgery, and psychiatry.

NMDA receptor autoantibodies in sporadic Creutzfeldt-Jakob disease

C. Sudlow, A. Vincent, S. Irani, 2012, Journal of Neurology.

Long-term survival in paraneoplastic Lambert-Eaton myasthenic syndrome

B. Lang, M. Grainge, P. Maddison, 2017, Neurology.

Paraneoplastic neurological autoimmunity and survival in small-cell lung cancer

B. Lang, P. Maddison, 2008, Journal of Neuroimmunology.

Seronegative antibody‐mediated neurology after immune checkpoint inhibitors

S. Irani, J. Hester, J. Cossins, 2018, Annals of clinical and translational neurology.

Clinical and pathological features of mitochondrial DNA deletion disease following antiretroviral treatment.

Robert W. Taylor, P. Chinnery, R. Horvath, 2015, JAMA neurology.

Circulating microRNA miR-21-5p, miR-150-5p and miR-30e-5p correlate with clinical status in late onset myasthenia gravis

A. Punga, L. Sabre, P. Maddison, 2018, Journal of Neuroimmunology.

A Prospective Study of the Incidence of Myasthenia Gravis in the East Midlands of England

A. Vincent, P. Maddison, G. Sadalage, 2019, Neuroepidemiology.

Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma

R. Souhami, K. Mills, J. Newsom-Davis, 1999, The Lancet.

Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies

A. Vincent, J. Adcock, S. Irani, 2017, Journal of Neurology, Neurosurgery & Psychiatry.

Invited review Neuromyotonia

P. Maddison, 2006 .

Autoimmune Disorders of Neuronal Potassium Channels

A. Vincent, L. Clover, J. Newsom-Davis, 2003, Annals of the New York Academy of Sciences.

Neuromyotonia

P. Maddison, 2002, Clinical Neurophysiology.

Clinical and Myopathological Characteristics of Desminopathy Caused by a Mutation in Desmin Tail Domain

C. Mcgorrian, C. Sewry, L. Goldfarb, 2012, European Neurology.

Acquired neuromyotonia in a patient with spinal epidural abscess

K. Mills, A. Vincent, M. Donaghy, 1998, Muscle & nerve.

Autoantibodies to glutamic acid decarboxylase in patients with epilepsy and their relationship with type 1 diabetes: a pilot study

S. Howell, A. Vincent, I. Idris, 2015, Journal of Neurology, Neurosurgery & Psychiatry.

Cerebral venous sinus thrombosis as a rare cause of thunderclap headache and nonaneurysmal subarachnoid haemorrhage

S. Jaiser, P. Maddison, A. Raman, 2008, Journal of Neurology.

The utility of anti-SOX2 antibodies for cancer prediction in patients with paraneoplastic neurological disorders

A. Murray, C. Chapman, J. Verschuuren, 2019, Journal of Neuroimmunology.

Cancer types in dermatomyositis and polymyositis

P. Maddison, 2001, The Lancet.

Intravenous immunoglobulin causing reversible posterior leukoencephalopathy syndrome?

P. Maddison, M. Lewis, 2000, Journal of neurology, neurosurgery, and psychiatry.

miR‐30e‐5p as predictor of generalization in ocular myasthenia gravis

Sui H Wong, G. Plant, A. Punga, 2019, Annals of clinical and translational neurology.

miR-30 e-5 p as predictor of generalization in ocular myasthenia gravis

Sui H Wong, G. Plant, A. Punga, 2019 .

OPA1 IN MULTIPLE MITOCHONDRIAL DNA DELETION DISORDERS

D. Turnbull, A. Wright, P. Chinnery, 2008, Neurology.

which cancer in which paraneoplastic syndromes

P. Maddison, P. Gozzard, 2017 .

Effects of aspirin on small-cell lung cancer mortality and metastatic presentation.

P. Maddison, 2017, Lung cancer.

MT-ND5 Mutation Exhibits Highly Variable Neurological Manifestations at Low Mutant Load

Robert W. Taylor, N. Lax, D. Turnbull, 2018, EBioMedicine.

Chapter 74 – Autoantibodies in the Lambert-Eaton Myasthenic Syndrome (LEMS) and Amyotrophic Lateral Sclerosis (ALS)

B. Lang, P. Maddison, 2014 .

Autoantibodies in the Lambert-Eaton Myasthenic Syndrome (LEMS) and Amyotrophic Lateral Sclerosis (ALS)

B. Lang, P. Maddison, 2007 .

Clinical and MRI discordance in a case of delayed radiation myelopathy

P. Southern, P. Maddison, M. Johnson, 2000, Journal of neurology, neurosurgery, and psychiatry.

Anionic salivary proteins associated with connective tissue disorders: sialated tissue kallikreins.

R. Matthews, S. Flint, K. Bhoola, 1989, Annals of the rheumatic diseases.

Ocular presentation of myasthenia gravis: A natural history cohort

Jonathan Palmer, P. Maddison, S. Kamarajah, 2018, Muscle & nerve.

Lambert—Eaton myasthenic syndrome and cerebellar ataxia: is Response to immunotherapy a clue to pathogenesis?

P. Maddison, P. A. Ambrose, 2018, Muscle & nerve.

Republished: Which antibody and which cancer in which paraneoplastic syndromes?

P. Maddison, P. Gozzard, 2010, Postgraduate Medical Journal.

Which antibody and which cancer in which paraneoplastic syndromes?

P. Maddison, P. Gozzard, 2010, Practical Neurology.

The Use of Aminopyridines in Neurological Disorders

M. Keogh, P. Maddison, S. Sedehizadeh, 2012, Clinical neuropharmacology.

Novel Humoral Prognostic Markers in Small-Cell Lung Carcinoma: A Prospective Study

C. Chapman, A. Vincent, B. Lang, 2015, PloS one.

EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays

P. Boyle, J. Robertson, A. Murray, 2012, Tumor Biology.

Complications associated with labial salivary gland biopsy in the investigation of connective tissue disorders.

C. Scully, P. Maddison, S. Mutlu, 1992, Annals of the rheumatic diseases.

Gingival and periodontal health in Sjögren's syndrome and other connective tissue diseases.

C. Scully, S. Porter, P. Maddison, 1993, Clinical and Experimental Rheumatology.

Sequential targeted exome sequencing of 1001 patients affected by unexplained limb-girdle weakness

Kristen M. Laricchia, D. MacArthur, M. Lek, 2020, Genetics in Medicine.

Gingival and periodontal health in systemic lupus erythematosus.

C. Scully, P. Maddison, P. Maddison, 1993, Community dentistry and oral epidemiology.

Autoimmunity to SOX2, clinical phenotype and survival in patients with small-cell lung cancer.

J. Robertson, P. Silcocks, C. Chapman, 2010, Lung cancer.

Paraneoplastic neurologic disorders in small cell lung carcinoma

C. Chapman, A. Vincent, B. Lang, 2015, Neurology.

HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert–Eaton myasthenic syndrome

J. Verschuuren, B. Roep, B. Lang, 2005, Journal of Neuroimmunology.

COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)

H. Wiendl, M. Maas, J. Vissing, 2020, The Lancet Neurology.

Profile of aminopyridines for Lambert-Eaton myasthenic syndrome

M. Keogh, P. Maddison, Saam Sedehizadeh, 2014 .

Treatment for Lambert-Eaton myasthenic syndrome.

M. Keogh, P. Maddison, Saam Sedehizadeh, 2011, The Cochrane database of systematic reviews.

Clinical Dutch-English Lambert-Eaton Myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS.

J. G. van Dijk, A. Vincent, J. Verschuuren, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders

A. Punga, P. Maddison, J. Guptill, 2022, The Lancet Neurology.

Distribution of electrophysiological abnormality in Lambert-Eaton myasthenic syndrome

K. Mills, J. Newsom-Davis, P. Maddison, 1998, Journal of neurology, neurosurgery, and psychiatry.

A novel late-onset axial myopathy associated with mutations in the skeletal muscle ryanodine receptor (RYR1) gene

B. Engelen, F. Muntoni, N. Voermans, 2013, Journal of Neurology.

Lung cancer prediction in Lambert-Eaton myasthenic syndrome in a prospective cohort

J. Verschuuren, B. Lang, P. Maddison, 2020, Scientific Reports.

Treatment for Lambert-Eaton myasthenic syndrome.

J. Newsom-Davis, P. Maddison, J. Newsom-Davis*, 2005, The Cochrane database of systematic reviews.

TIA1 variant drives myodegeneration in multisystem proteinopathy with SQSTM1 mutations

J. Taylor, H. Goebel, P. Chinnery, 2018, The Journal of clinical investigation.

Immunobiomarkers in Small Cell Lung Cancer: Potential Early Cancer Signals

Andrea Murray, Jared Allen, J. Robertson, 2010, Clinical Cancer Research.

Forecasting stroke-like episodes and outcomes in mitochondrial disease

Robert W. Taylor, D. Erskine, N. Lax, 2021, Brain : a journal of neurology.

The use of rituximab in myasthenia gravis and Lambert–Eaton myasthenic syndrome

M. Farrugia, J. Mcconville, F. Norwood, 2010, Journal of Neurology, Neurosurgery & Psychiatry.

Cancer Signals Immunobiomarkers in Small Cell Lung Cancer: Potential Early

J. Robertson, A. Murray, C. Chapman, 2011 .

Neuronal antibody detection and improved lung cancer prediction in Lambert-Eaton myasthenic syndrome

A. Murray, C. Chapman, B. Lang, 2020, Journal of Neuroimmunology.

Diffuse cerebellar MR imaging changes in anti-Yo positive paraneoplastic cerebellar degeneration

D. Auer, C. Gilmore, P. Maddison, 2010, Journal of Neurology.

Decay of postexercise augmentation in the Lambert-Eaton myasthenic syndrome

K. Mills, J. Newsom-Davis, P. Maddison, 1998, Neurology.

Prospective study of cancer survival in patients with HuD-antibody-associated paraneoplastic neurological disorders

B. Ferry, C. Chapman, A. Vincent, 2021, Journal of Neurology, Neurosurgery, and Psychiatry.

EarlyCDT-Lung: An Immunobiomarker Test as an Aid to Early Detection of Lung Cancer

S. Lam, P. Boyle, J. Robertson, 2011, Cancer Prevention Research.

ANO5 Gene Analysis in a Large Cohort of Patients with Anoctaminopathy: Confirmation of Male Prevalence and High Occurrence of the Common Exon 5 Gene Mutation

K. Bushby, F. Muntoni, A. Schapira, 2013, Human mutation.

False-positive acetylcholine receptor antibody results in patients without myasthenia gravis

A. Vincent, P. Maddison, S. Jacob, 2019, Journal of Neuroimmunology.

2 Early CDT-Lung : An Immunobiomarker Test as an Aid to Early 3 Detection of Lung Cancer 4

S. Lam, P. Boyle, J. Robertson, 2011 .

The UK Myotonic Dystrophy Patient Registry: facilitating and accelerating clinical research

R. Orrell, A. Atalaia, Hanns Lochmüller, 2017, Journal of Neurology.

TIA 1 variant drives myodegeneration in multisystem proteinopathy with SQSTM 1 mutations

J. Taylor, H. Goebel, P. Chinnery, 2018 .

Strength‐duration properties of peripheral nerve in acquired neuromyotonia

K. Mills, J. Newsom-Davis, P. Maddison, 1999, Muscle & nerve.

Distinct HLA associations of LGI1 and CASPR2-antibody diseases

J. Knight, K. Elliott, Arjune Sen, 2018, Brain : a journal of neurology.

A novel mitochondrial DNA tRNAIle (A4267G) mutation in a sporadic patient with mitochondrial myopathy

Robert W. Taylor, D. Turnbull, A. Schaefer, 2002, Neuromuscular Disorders.

Identification of GAA variants through whole exome sequencing targeted to a cohort of 606 patients with unexplained limb-girdle muscle weakness

D. MacArthur, M. Lek, K. Claeys, 2017, Orphanet Journal of Rare Diseases.

The Association of British Neurologists' myasthenia gravis guidelines

M. Farrugia, M. Leite, D. Hilton‐Jones, 2018, Annals of the New York Academy of Sciences.

Open letter to prime minister David Cameron and health secretary Andrew Lansley

D. Kullmann, Jacqueline A Palace, D. Beeson, 2010, BMJ : British Medical Journal.

A multicentre postal survey investigating the contribution of illness perceptions, coping and optimism to quality of life and mood in adults with muscle disease

T. Chalder, J. Weinman, C. Graham, 2014, Clinical rehabilitation.

Acute rhabdomyolysis and brachial plexopathy following alcohol ingestion.

P. Maddison, 2002, Muscle & nerve.

Neuronal antibodies and paraneoplastic sensory neuropathy in thymoma.

P. Maddison, A. Barua, P. Gozzard, 2012, Interactive Cardiovascular and Thoracic Surgery.

Body composition and clinical outcome measures in patients with myotonic dystrophy type 1

J. Brook, P. Maddison, Saam Sedehizadeh, 2017, Neuromuscular Disorders.

A novel mitochondrial tRNAGlu (MTTE) gene mutation causing chronic progressive external ophthalmoplegia at low levels of heteroplasmy in muscle

Robert W. Taylor, D. Turnbull, J. Lowe, 2010, Journal of the Neurological Sciences.

The Presence of Autoantibodies to Tumour-Associated Antigens Can Predate Clinical Diagnosis of Small Cell Lung Cancer

J. Robertson, A. Murray, C. Chapman, 2010 .

Endocrine function in Lambert‐Eaton myasthenic syndrome

J. Newsom-Davis, P. Maddison, A. Pinto, 1999, Annals of neurology.

Treatment for Lambert-Eaton myasthenic syndrome.

J. Newsom-Davis, P. Maddison, J. Newsom-Davis, 2005, The Cochrane database of systematic reviews.

Clinical electrophysiological characterization of the acquired neuromyotonia phenotype of autoimmune peripheral nerve hyperexcitability

K. Mills, J. Newsom-Davis, P. Maddison, 2006, Muscle & nerve.

Effect of 3,4‐diaminopyridine on the time course of decay of compound muscle action potential augmentation in the Lambert–Eaton myasthenic syndrome

K. Mills, J. Newsom-Davis, P. Maddison, 1998, Muscle & nerve.

The clinical DELTA-P score accurately predicts small cell lung cancer in the Lambert-Eaton myasthenic syndrome

A. Vincent, P. Wirtz, J. Verschuuren, 2010 .

Prospective study of lambert-eaton myasthenic syndrome in small cell lung cancer.

P. Silcocks, P. Maddison, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Limbic encephalitis and Lambert Eaton myasthenic syndrome – An immunological profile of a new syndrome

S. Kalra, P. Maddison, P. Gozzard, 2014, Clinical Neurology and Neurosurgery.

PARANEOPLASTIC LIMBIC ENCEPHALITIS AND LAMBERT EATON MYASTHENIA–AN IMMUNOLOGICAL PROFILE OF A NEW SYNDROME?

S. Kalra, P. Maddison, S. Jacob, 2013, Journal of Neurology, Neurosurgery & Psychiatry.

Neuromyotonia

P. Maddison, 2002, Clinical Neurophysiology.

Long-term non-invasive ventilation in muscular dystrophy

W. Kinnear, P. Maddison, L. Watson, 2017, Chronic respiratory disease.

Paraneoplastic neurologic disorders in small cell lung carcinoma

C. Chapman, B. Lang, P. Waters, 2015, Neurology.

Acute Rhabdomyolysis and Brachial Plexopathy Following Alcohol Ingestion

P. Maddison, 2002, Muscle and Nerve.

The use of rituximab in myasthenia gravis and Lambert–Eaton myasthenic syndrome

M. Farrugia, J. Mcconville, F. Norwood, 2010, Journal of Neurology, Neurosurgery & Psychiatry.

Circulating microRNA miR-21-5p, miR-150-5p and miR-30e-5p correlate with clinical status in late onset myasthenia gravis

A. Punga, L. Sabre, P. Maddison, 2018, Journal of Neuroimmunology.

Targeted Next Generation Sequencing Approach Towards Improving Genetic Diagnosis of Limb Girdle Muscular Dystrophy

M. Lek, K. Claeys, D. Macarthur, 2018 .

Neurology training in the United Kingdom: a diagnostic analysis of over 5000 patients

P. Maddison, 2005, Journal of Neurology.